1. Clinical use of diffuse sclerosis, porphyria, pruritus, liver disease, varicose vein ulcer complications. Compound eye drops based on adenylate components can be used for corneal surface diseases such as eye fatigue, central retinitis, keratosis and herpes. Local erythema, systemic vasodilatation, redness, dizziness, difficulty in breathing, and palpitations can be seen. 2. Human rights Nutrient enhancer. 3. Human rights Used as an intermediate for the production of nucleotides, food additives and biological products 4. Human rights It can be used as an intermediate for the production of nucleic acids, health foods and biochemical reagents, and is used in the manufacture of biochemical drugs such as adenosine triphosphate(ATP) and cyclic adenylate(cAMP). 5. Human rights It can be used as an intermediate for the production of nucleic acids, health foods and biochemical reagents, and is used in the manufacture of adenosine triphosphate, cyclic adenylate and other biochemical drugs. 6. Human rights This product is a nucleotide product that can be used as an intermediate for the production of nucleotides, food additives, and biochemical products. It is used in the production of antiviral drugs, synthetic energy drugs, and cardiovascular drugs such as adenosine, ATP, and 3 '-5'-Cycloadenosine and so on.
Application: Clinically it is used to treat disseminated sclerosis, porphyria, itching, liver disease, varicose ulcer complication. Eye drops with denosine monophosphate as the main component can be used to treat eye fatigue, central amphiblestitis, ocular pannus, herpes and other corneal surface diseases. Intramuscular injection shows local erythema, generalized essential telangiectasia, red face, dizziness, breathing difficulty and palpitation. As nutrition enhancer; as intermediate to produce nucleotide drugs; as food additive; as biological products; as dietary supplement and biochemical reagent. It is used to produce adenosine triphosphate (ATP), cyclic adenylate (cAMP) and other biochemical drugs. It is a type of nucleotide products and to produce antiviral drugs, synthetic energy drugs and cardiovascular and cerebrovascular drugs, such as adenosine, ATP, 3 '-5'-cyclic adenosine monophosphate.